跳至主要内容
临床试验/NCT03491878
NCT03491878Unknown不适用

Three Dimension Laparoscopic Versus Open Surgery for Gallbladder Carcinoma. A Randomized Clinical Trial

Tongji Hospital2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
200
试验地点
2
主要终点
Complication rate

研究概览

简要总结

Introduction: Surgery is the only potential curative approach for the highly lethal gallbladder carcinoma. The laparoscopic surgery has developed rapidly since invented. As a kind of minimally invasive surgery, laparoscopic cholecystectomy including segmentg IVB and V is preferred by most of surgeons. There have been studies comparing intraoperative blood loss, postoperative morbidity, length of hospital stay and costs of laparoscopic cholecystectomy over open surgery. However, randomized controlled trials are still lacking but clearly required to reveal whether the laparoscopic approach or the open surgery is the better option for treating gallbladder carcinoma. We hypothesize that incidence of postoperative complications is lower, and time to functional recovery is shorter after laparosopic compared with open approach, even in an enhanced recovery setting.

Methods/design: We designed this prospective, randomized, controlled trial with two treatment approaches, laparoscopic versus open surgery for gallbladder carcinoma. The trial hypothesis is that laparoscopic approach has advantages in postoperative recoveries and be equivalent in operation time, oncological results and long-term follow-up compared with open counterpart. The duration of the entire trial is four years including prearrangement, follow-up and analyses.

Discussion: Although several studies have discussed different surgical approaches for gallbladder carcinoma treatment, this trial will be a thorough RCT comparing laparoscopic and open surgery for gallbladder carcinoma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically proven gallbladder carcinoma.
  • Highly presumed malignancy with difficulties to obtain histological evidence.
  • Preoperative staging work up performed by upper abdomen enhanced CT scan and showed no vessel involvment.
  • The subject understands the nature of this trial and willing to comply.
  • Ability to provide written informed consent.
  • Patients treated with curative intent in accordance to international guidelines.

排除标准

  • Distant metastases: peritoneal carcinomatosis, liver metastases, distant lymph node metastases, involvement of other organs.
  • Patients with high operative risk as defined by the American Society of Anesthesiologists (ASA) score >
  • Synchronous malignancy in other organs.
  • Palliative surgery.

研究组 & 干预措施

3D approach

Experimental

Three dimensional laparoscopic cholecystectomy including segments IVB and V

干预措施: Three dimensional laparoscopic (Procedure)

open approach

Active Comparator

Open cholecystectomy including segments IVB and V

干预措施: Open (Procedure)

结局指标

主要结局

Complication rate

时间窗: 24 months

Complication rate is defined as the number of subjects developed complication divided the total subjects number

R0 rescetion rate

时间窗: 24 months

R0 rescetion rate for the carcinoma

Length of stay

时间窗: 24 months

LOS is defined as the days between the surgery and hospital discharged

Operation time

时间窗: 24 months

Operation time is definied as the from either skin incision or trocar placement to the entire skin closure.

Estimated blood loss

时间窗: 24 months

EBL is defined as the blood loss during the surgical procedure

Intraoperative blood transfusion

时间窗: 24 months

IBT is defined as whether the subjects receive blood transfusion during the surgical procedure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Renyi Qin

Professor

Tongji Hospital

研究点 (2)

Loading locations...

相似试验